Press Releases

Media Update: Sanofi completes acquisition of Qunol®

Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority Review

Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A

Press Release: Availability of the Q3 2023 Memorandum for modelling purposes

Press Release: Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change

Media Update: New data at ERS showed Xenpozyme® (olipudase alfa) improved respiratory functions in adults with ASMD

Media Update: New data at ERS showcases Sanofi's scientific leadership in addressing unmet needs across a variety of respiratory conditions 

Press Release: Sanofi announces changes to its Executive Committee

Press Release: Sanofi, Meningitis Research Foundation, and the Confederation of Meningitis Organisations ignite a global awareness initiative against meningitis with launch of The Meningitis Flag

Press Release: U.S. CDC Advisory Committee unanimously recommends routine use of Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease

Press release: Online availability of Sanofi’s half-year financial report for 2023

Press Release: Sanofi to acquire Qunol®, a fast-growing U.S. brand in the healthy aging segment

Press Release: Solid Q2 performance and strong pipeline momentum, Full-year 2023 business EPS guidance raised

Press Release: FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease

Press Release: Vaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal disease

Press Release: Positive topline Phase 2b data in atopic dermatitis support amlitelimab as a potential first and best-in-class novel investigational anti-OX40-ligand monoclonal antibody

Press Release: ALTUVIIIO late-breaking data at ISTH demonstrates highly effective bleed protection in children with severe hemophilia A with once-weekly dosing

Press Release: Availability of the Q2 2023 Memorandum for modelling purposes

Press Release: Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim

Press Release: Sanofi Consumer Healthcare launches new portal to unlock science and solve key challenges in self-care